Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remune and Exercise for Cancer Cachexia
NCT04131426Phase 1Completed
- Sponsor
- University of Rochester
- Start
- Apr 2020
- Primary completion
- Jan 2021
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial (3 arms), sponsored by University of Rochester. Primary endpoints: Incidence of Treatment-Emergent Adverse Events at 3 months, Adherence at 3 months and 1 more. Started Apr 2020; status: completed.
Beyond the preview
Go deeper on NCT04131426.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04131426.